Institutional Ownership Xenon Pharmaceuticals Inc. (XENE)
This table provides information about the institutional ownership of Xenon Pharmaceuticals Inc. (XENE). We have compiled data on the 219 institutions that hold shares in the stock, with a total of 70.1 Million shares, which have been reported (via 13F filing form) to have a value of $2.29 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Times Square Capital Management, LLC
|
May 02, 2025 Q1 2025 |
745,551
shares
|
$24.4 Million
0.43% of portfolio
|
Q1 2025
Reduced 12.17%
|
|
|
Siren, L.L.C.
New York, NY |
May 14, 2025 Q1 2025 |
732,761
shares
|
$23.9 Million
1.4% of portfolio
|
Q1 2025
Reduced 1.48%
|
|
|
Bnp Paribas Asset Management Holding S.A.
|
May 13, 2025 Q1 2025 |
703,795
shares
|
$23 Million
0.06% of portfolio
|
Q1 2025
Added 6.04%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
687,088
shares
|
$22.5 Million
0.0% of portfolio
|
Q1 2025
Added 109.92%
|
|
|
First Turn Management, LLC
Del Mar, CA |
May 15, 2025 Q1 2025 |
683,451
shares
|
$22.3 Million
4.62% of portfolio
|
Q1 2025
Reduced 0.22%
|
|
|
Loomis Sayles & CO L P
|
May 14, 2025 Q1 2025 |
673,011
shares
|
$22 Million
0.03% of portfolio
|
Q1 2025
Reduced 2.06%
|
|
|
Logos Global Management LP
San Francisco, CA |
May 15, 2025 Q1 2025 |
650,000
shares
|
$21.2 Million
4.25% of portfolio
|
Q1 2025
New holding
|
|
|
First Light Asset Management, LLC
Edina, MN |
May 15, 2025 Q1 2025 |
627,904
shares
|
$20.5 Million
2.7% of portfolio
|
Q1 2025
Reduced 45.9%
|
|
|
Fiera Capital Corp
Montreal, A8 |
May 07, 2025 Q1 2025 |
529,442
shares
|
$17.3 Million
0.07% of portfolio
|
Q1 2025
Reduced 1.2%
|
|
|
Franklin Resources Inc
San Mateo, CA |
May 13, 2025 Q1 2025 |
491,120
shares
|
$16 Million
0.0% of portfolio
|
Q1 2025
Reduced 14.68%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
454,650
shares
|
$14.9 Million
0.1% of portfolio
|
Q1 2025
Reduced 7.63%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
442,732
shares
|
$14.5 Million
0.0% of portfolio
|
Q1 2025
Added 7.92%
|
|
|
Assenagon Asset Management S.A.
|
Jul 11, 2025 Q2 2025 |
436,974
shares
|
$14.3 Million
0.02% of portfolio
|
Q2 2025
Added 81.16%
|
|
|
Saturn V Capital Management LLC
Austin, TX |
May 15, 2025 Q1 2025 |
413,711
shares
|
$13.5 Million
7.0% of portfolio
|
Q1 2025
Added 28.29%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
404,154
shares
|
$13.2 Million
0.03% of portfolio
|
Q1 2025
Added 42.36%
|
|
|
Alyeska Investment Group, L.P.
Chicago, IL |
May 15, 2025 Q1 2025 |
367,233
shares
|
$12 Million
0.05% of portfolio
|
Q1 2025
Added 27.14%
|
|
|
Baker Bros. Advisors LP
New York, NY |
May 15, 2025 Q1 2025 |
347,408
shares
|
$11.4 Million
0.14% of portfolio
|
Q1 2025
Reduced 65.04%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
336,514
shares
|
$11 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.83%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2025 Q1 2025 |
325,324
shares
|
$10.6 Million
0.46% of portfolio
|
Q4 2024
Reduced 38.03%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
305,620
shares
|
$9.99 Million
0.0% of portfolio
|
Q1 2025
Added 5.85%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
303,398
shares
|
$9.92 Million
1.88% of portfolio
|
Q1 2025
Added 53.84%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
298,800
shares
|
$9.76 Million
0.02% of portfolio
|
Q1 2025
Added 0.03%
|
|
|
Stem Point Capital LP
New York, NY |
May 15, 2025 Q1 2025 |
274,633
shares
|
$8.98 Million
2.94% of portfolio
|
Q1 2025
Reduced 26.93%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
May 15, 2025 Q1 2025 |
273,739
shares
|
$8.95 Million
2.77% of portfolio
|
Q1 2024
Reduced 1.08%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
267,142
shares
|
$8.73 Million
0.02% of portfolio
|
Q1 2025
Added 44.73%
|